Capstone Investment Advisors’s Medicines Co MDCO Stock Holding History

Capstone Investment Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-145,000	Closed	-$12.3M	–	1460
2019 Q4	$12.3M	Buy	145,000 +73,300	+102%	+$4.89M	0.07%	304
2019 Q3	$3.58M	Buy	71,700 +43,400	+153%	+$1.73M	0.02%	557
2019 Q2	$1.03M	Hold	28,300	–	–	0.01%	936
2019 Q1	$791K	Buy	+28,300	New	+$667K	0.01%	881
2018 Q1	–	Sell	-25,000	Closed	-$683K	–	604
2017 Q4	$683K	Hold	25,000	–	–	0.02%	233
2017 Q3	$926K	Buy	+25,000	New	+$922K	0.03%	226
2017 Q2	–	Sell	-16,100	Closed	-$787K	–	1033
2017 Q1	$787K	Buy	+16,100	New	+$734K	0.02%	487

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Capstone Investment Advisors's MDCO Position: Q1 2020 in Review

Capstone Investment Advisors sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 700 shares — an estimated $59K sold.

Capstone Investment Advisors first reported a position in MDCO in Q3 2016 and held it in 4 quarters. The position peaked at $1.56M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Capstone Investment Advisors reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Capstone Investment Advisors sold 700 Medicines Co shares in Q1 2020, an estimated $59K.
Capstone Investment Advisors first reported a position in Medicines Co in Q3 2016 and held it in 4 quarters.
Capstone Investment Advisors's Medicines Co position peaked at $1.56M in Q3 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Capstone Investment Advisors's 13F filing for Q1 2020, filed 15 May 2020.